Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21890163 | 0.92 | KDM4E (0.30) | KDM4E | |
| SCHEMBL21890169 | 0.91 | FEN1 (0.31) | FEN1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL21890261 | 0.84 | ACHE (0.35) | FEN1ALDH1A1TSHRCYP2C19KDM4E | |
| SCHEMBL21890403 | 0.83 | KDM4E (0.35) | FEN1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL21890526 | 0.81 | FEN1 (0.32) | FEN1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL21890406 | 0.81 | KDM4E (0.38) | FEN1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL23948825 | 0.79 | KDM4E (0.40) | FEN1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL21890604 | 0.79 | KDM4E (0.33) | KDM4E | |
| SCHEMBL23948609 | 0.79 | KDM4E (0.46) | FEN1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL21890172 | 0.78 | FEN1 (0.32) | FEN1PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230068759-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2023-03-02 | — | — | US | disclosed |
| US-20200227656-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2020-07-16 | — | — | US | disclosed |
| US-10615349-B2 | Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200227656-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | SUN2, STAU1, HELZ | FEN1 1162/4885PDE4A 3148/4885PDE4B 3840/4885 |
| US-20230068759-A1 | DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES | SUN2, STAU1, HELZ | FEN1 1162/4885PDE4A 3148/4885PDE4B 3840/4885 |
| US-10615349-B2 | Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues | SUN2, STAU1, HELZ | FEN1 1162/4885PDE4A 3148/4885PDE4B 3840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.